ANDLAUER HEALTHCARE GROUP IN (AND.CA) Fundamental Analysis & Valuation
TSX:AND • CA0342231077
Current stock price
54.97 CAD
+0.01 (+0.02%)
Last:
This AND.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. AND.CA Profitability Analysis
1.1 Basic Checks
- AND had positive earnings in the past year.
- AND had a positive operating cash flow in the past year.
- AND had positive earnings in each of the past 5 years.
- In the past 5 years AND always reported a positive cash flow from operatings.
1.2 Ratios
- AND's Return On Assets of 9.81% is fine compared to the rest of the industry. AND outperforms 80.00% of its industry peers.
- AND has a Return On Equity of 15.35%. This is amongst the best in the industry. AND outperforms 86.67% of its industry peers.
- AND has a Return On Invested Capital of 11.76%. This is amongst the best in the industry. AND outperforms 86.67% of its industry peers.
- AND had an Average Return On Invested Capital over the past 3 years of 11.97%. This is above the industry average of 7.06%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.81% | ||
| ROE | 15.35% | ||
| ROIC | 11.76% |
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
1.3 Margins
- AND has a Profit Margin of 10.37%. This is amongst the best in the industry. AND outperforms 86.67% of its industry peers.
- AND's Profit Margin has been stable in the last couple of years.
- AND has a Operating Margin of 13.99%. This is amongst the best in the industry. AND outperforms 86.67% of its industry peers.
- In the last couple of years the Operating Margin of AND has remained more or less at the same level.
- AND has a worse Gross Margin (33.85%) than 60.00% of its industry peers.
- AND's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.99% | ||
| PM (TTM) | 10.37% | ||
| GM | 33.85% |
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
2. AND.CA Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AND is creating some value.
- Compared to 1 year ago, AND has less shares outstanding
- Compared to 5 years ago, AND has more shares outstanding
- The debt/assets ratio for AND is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 6.13 indicates that AND is not in any danger for bankruptcy at the moment.
- With an excellent Altman-Z score value of 6.13, AND belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
- The Debt to FCF ratio of AND is 1.80, which is an excellent value as it means it would take AND, only 1.80 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 1.80, AND belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- AND has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
- AND's Debt to Equity ratio of 0.21 is amongst the best of the industry. AND outperforms 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.8 | ||
| Altman-Z | 6.13 |
ROIC/WACC1.44
WACC8.16%
2.3 Liquidity
- A Current Ratio of 1.35 indicates that AND should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.35, AND belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
- A Quick Ratio of 1.30 indicates that AND should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.30, AND belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.3 |
3. AND.CA Growth Analysis
3.1 Past
- The Earnings Per Share has been growing slightly by 1.96% over the past year.
- The Earnings Per Share has been growing by 14.82% on average over the past years. This is quite good.
- Looking at the last year, AND shows a small growth in Revenue. The Revenue has grown by 0.34% in the last year.
- The Revenue has been growing by 17.53% on average over the past years. This is quite good.
EPS 1Y (TTM)1.96%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%-10.53%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%-3%
3.2 Future
- The Earnings Per Share is expected to grow by 8.62% on average over the next years. This is quite good.
- Based on estimates for the next years, AND will show a small growth in Revenue. The Revenue will grow by 1.95% on average per year.
EPS Next Y6.54%
EPS Next 2Y10.13%
EPS Next 3Y8.62%
EPS Next 5YN/A
Revenue Next Year0.03%
Revenue Next 2Y1.88%
Revenue Next 3Y1.95%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. AND.CA Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 35.24, the valuation of AND can be described as expensive.
- 66.67% of the companies in the same industry are more expensive than AND, based on the Price/Earnings ratio.
- AND is valuated rather expensively when we compare the Price/Earnings ratio to 25.50, which is the current average of the S&P500 Index.
- AND is valuated quite expensively with a Price/Forward Earnings ratio of 28.68.
- Based on the Price/Forward Earnings ratio, AND is valued a bit cheaper than 73.33% of the companies in the same industry.
- AND is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.67, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.24 | ||
| Fwd PE | 28.68 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, AND is valued a bit cheaper than 66.67% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of AND is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.69 | ||
| EV/EBITDA | 14.03 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- AND has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.39
PEG (5Y)2.38
EPS Next 2Y10.13%
EPS Next 3Y8.62%
5. AND.CA Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.87%, AND is not a good candidate for dividend investing.
- AND's Dividend Yield is a higher than the industry average which is at 1.41.
- Compared to an average S&P500 Dividend Yield of 1.89, AND's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.87% |
5.2 History
- The dividend of AND decreases each year by -34.89%.
- AND has been paying a dividend for over 5 years, so it has already some track record.
- AND has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-34.89%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
- 26.73% of the earnings are spent on dividend by AND. This is a low number and sustainable payout ratio.
DP26.73%
EPS Next 2Y10.13%
EPS Next 3Y8.62%
AND.CA Fundamentals: All Metrics, Ratios and Statistics
TSX:AND (11/4/2025, 7:00:00 PM)
54.97
+0.01 (+0.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-11 2025-11-11/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners76.5%
Inst Owner ChangeN/A
Ins Owners2.53%
Ins Owner ChangeN/A
Market Cap2.15B
Revenue(TTM)650.58M
Net Income(TTM)67.49M
Analysts50
Price Target56.92 (3.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.87% |
Yearly Dividend0.42
Dividend Growth(5Y)-34.89%
DP26.73%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.25%
Min EPS beat(2)-19.85%
Max EPS beat(2)-10.65%
EPS beat(4)0
Avg EPS beat(4)-9.2%
Min EPS beat(4)-19.85%
Max EPS beat(4)-0.99%
EPS beat(8)1
Avg EPS beat(8)-8.84%
EPS beat(12)3
Avg EPS beat(12)-6.41%
EPS beat(16)5
Avg EPS beat(16)11.49%
Revenue beat(2)0
Avg Revenue beat(2)-4.56%
Min Revenue beat(2)-7.25%
Max Revenue beat(2)-1.87%
Revenue beat(4)0
Avg Revenue beat(4)-3.59%
Min Revenue beat(4)-7.25%
Max Revenue beat(4)-1.87%
Revenue beat(8)1
Avg Revenue beat(8)-3.17%
Revenue beat(12)4
Avg Revenue beat(12)-1.94%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.43%
EPS NY rev (1m)-0.79%
EPS NY rev (3m)-6.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.24 | ||
| Fwd PE | 28.68 | ||
| P/S | 3.31 | ||
| P/FCF | 21.69 | ||
| P/OCF | 17.59 | ||
| P/B | 4.89 | ||
| P/tB | 17.04 | ||
| EV/EBITDA | 14.03 |
EPS(TTM)1.56
EY2.84%
EPS(NY)1.92
Fwd EY3.49%
FCF(TTM)2.53
FCFY4.61%
OCF(TTM)3.13
OCFY5.69%
SpS16.62
BVpS11.23
TBVpS3.23
PEG (NY)5.39
PEG (5Y)2.38
Graham Number19.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.81% | ||
| ROE | 15.35% | ||
| ROCE | 16.09% | ||
| ROIC | 11.76% | ||
| ROICexc | 13.13% | ||
| ROICexgc | 34.45% | ||
| OM | 13.99% | ||
| PM (TTM) | 10.37% | ||
| GM | 33.85% | ||
| FCFM | 15.25% |
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
ROICexc(3y)12.48%
ROICexc(5y)13.78%
ROICexgc(3y)30.54%
ROICexgc(5y)29.2%
ROCE(3y)16.39%
ROCE(5y)17.47%
ROICexgc growth 3Y-1.36%
ROICexgc growth 5Y-1.14%
ROICexc growth 3Y4.48%
ROICexc growth 5Y-13.43%
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
F-Score5
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.8 | ||
| Debt/EBITDA | 0.56 | ||
| Cap/Depr | 32.65% | ||
| Cap/Sales | 3.56% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 75.6% | ||
| Profit Quality | 147.02% | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 6.13 |
F-Score5
WACC8.16%
ROIC/WACC1.44
Cap/Depr(3y)36.55%
Cap/Depr(5y)30.34%
Cap/Sales(3y)3.8%
Cap/Sales(5y)3.06%
Profit Quality(3y)141.22%
Profit Quality(5y)125.45%
High Growth Momentum
Growth
EPS 1Y (TTM)1.96%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%-10.53%
EPS Next Y6.54%
EPS Next 2Y10.13%
EPS Next 3Y8.62%
EPS Next 5YN/A
Revenue 1Y (TTM)0.34%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%-3%
Revenue Next Year0.03%
Revenue Next 2Y1.88%
Revenue Next 3Y1.95%
Revenue Next 5YN/A
EBIT growth 1Y-1.92%
EBIT growth 3Y8.43%
EBIT growth 5Y15.86%
EBIT Next Year74.49%
EBIT Next 3Y25.3%
EBIT Next 5YN/A
FCF growth 1Y6.06%
FCF growth 3Y11.81%
FCF growth 5Y13.66%
OCF growth 1Y-1.91%
OCF growth 3Y13.94%
OCF growth 5Y15.32%
ANDLAUER HEALTHCARE GROUP IN / AND.CA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?
ChartMill assigns a fundamental rating of 6 / 10 to AND.CA.
What is the valuation status of ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?
ChartMill assigns a valuation rating of 3 / 10 to ANDLAUER HEALTHCARE GROUP IN (AND.CA). This can be considered as Overvalued.
How profitable is ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?
ANDLAUER HEALTHCARE GROUP IN (AND.CA) has a profitability rating of 7 / 10.
What is the earnings growth outlook for ANDLAUER HEALTHCARE GROUP IN?
The Earnings per Share (EPS) of ANDLAUER HEALTHCARE GROUP IN (AND.CA) is expected to grow by 6.54% in the next year.
Is the dividend of ANDLAUER HEALTHCARE GROUP IN sustainable?
The dividend rating of ANDLAUER HEALTHCARE GROUP IN (AND.CA) is 3 / 10 and the dividend payout ratio is 26.73%.